Cart
sales@molnova.com
ML401
CAS No. 1597489-14-9
ML401( —— )
Catalog No. M22038 CAS No. 1597489-14-9
ML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 306 | In Stock |
|
| 25MG | 487 | In Stock |
|
| 50MG | 641 | In Stock |
|
| 100MG | 830 | In Stock |
|
| 200MG | 1135 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML401
-
NoteResearch use only, not for human use.
-
Brief DescriptionML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
-
DescriptionML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
-
In VitroML401 shows no toxicity (>50 μM) towards immortalized Fa2-N4 human hepatocytes and non-cytotoxic in MTT in both LnCap and IMR-32 cells (>50 μM).
-
In VivoML401 shows very good stability in both human plasma and mouse plasma.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR183
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1597489-14-9
-
Formula Weight419.74
-
Molecular FormulaC20H20BrClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mg/mL (23.82 mM; Need ultrasonic)
-
SMILESC1CN(CCN1CC2=CC=C(C=C2)Cl)C(=O)C=CC3=CC=C(C=C3)Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ardecky R, et al. Functional Antagonists of EBI-2. Probe Reports from the NIH Molecular Libraries Program [Internet].
molnova catalog
related products
-
NIBR189
NIBR189 is a potent and selective antagonist of EBI2 (GPR183) receptor ?(IC50 of 11 and 15 nM for human and mouse EBI2 receptors respectively).
-
GPR35 agonist 2
GPR35 agonist 2 (TC-G 1001) is a potent GPR35 agonist.The EC50 values of GPR35 agonist 2 in the β-arrestin and Ca2+ release assays were 26 and 3.2 nM, respectively.
-
AS 1269574
AS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
